PECAM1 and kidney cancer: Next, we evaluated the role of KDM4D in angiopoiesis of kidney cancer and found that KDM4D inhibition markedly impaired neovascularization in vitro and in vivo by HUVEC tube formation assay and immumohistochemical staining of CD31.